A detailed history of Perennial Investment Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, Perennial Investment Advisors, LLC holds 2,690 shares of AMGN stock, worth $790,860. This represents 0.11% of its overall portfolio holdings.

Number of Shares
2,690
Previous 2,637 2.01%
Holding current value
$790,860
Previous $823,000 5.22%
% of portfolio
0.11%
Previous 0.12%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$309.38 - $337.38 $16,397 - $17,881
53 Added 2.01%
2,690 $866,000
Q2 2024

Aug 09, 2024

SELL
$262.75 - $319.31 $66,475 - $80,785
-253 Reduced 8.75%
2,637 $823,000
Q1 2024

May 14, 2024

SELL
$268.87 - $324.56 $4,839 - $5,842
-18 Reduced 0.62%
2,890 $821,000
Q4 2023

Feb 14, 2024

BUY
$255.7 - $288.46 $14,063 - $15,865
55 Added 1.93%
2,908 $837,000
Q3 2023

Nov 14, 2023

BUY
$218.65 - $271.46 $1,749 - $2,171
8 Added 0.28%
2,853 $766,000
Q2 2023

Aug 14, 2023

SELL
$214.27 - $253.37 $43,068 - $50,927
-201 Reduced 6.6%
2,845 $631,000
Q1 2023

May 11, 2023

BUY
$225.79 - $275.2 $90,993 - $110,905
403 Added 15.25%
3,046 $736,000
Q4 2022

Feb 09, 2023

BUY
$229.03 - $291.01 $2,519 - $3,201
11 Added 0.42%
2,643 $694,000
Q3 2022

Nov 09, 2022

BUY
$224.46 - $253.15 $114,699 - $129,359
511 Added 24.09%
2,632 $593,000
Q2 2022

Aug 10, 2022

BUY
$230.71 - $256.74 $18,456 - $20,539
80 Added 3.92%
2,121 $517,000
Q1 2022

May 09, 2022

BUY
$219.27 - $242.57 $50,212 - $55,548
229 Added 12.64%
2,041 $495,000
Q4 2021

Feb 14, 2022

BUY
$198.88 - $227.6 $69,210 - $79,204
348 Added 23.77%
1,812 $408,000
Q3 2021

Nov 12, 2021

BUY
$212.27 - $248.7 $424 - $497
2 Added 0.14%
1,464 $311,000
Q2 2021

Jul 29, 2021

BUY
$233.58 - $259.14 $700 - $777
3 Added 0.21%
1,462 $356,000
Q1 2021

Apr 29, 2021

SELL
$221.91 - $258.6 $9,098 - $10,602
-41 Reduced 2.73%
1,459 $363,000
Q4 2020

Jan 22, 2021

BUY
$216.38 - $257.67 $865 - $1,030
4 Added 0.27%
1,500 $345,000
Q3 2020

Oct 26, 2020

BUY
$234.65 - $260.95 $703 - $782
3 Added 0.2%
1,496 $380,000
Q2 2020

Jul 16, 2020

BUY
$197.81 - $242.74 $4,549 - $5,583
23 Added 1.56%
1,493 $352,000
Q1 2020

Apr 29, 2020

BUY
$182.24 - $241.7 $728 - $966
4 Added 0.27%
1,470 $298,000
Q4 2019

Feb 07, 2020

BUY
$189.21 - $243.2 $277,381 - $356,531
1,466 New
1,466 $353,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $157B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Perennial Investment Advisors, LLC Portfolio

Follow Perennial Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Perennial Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Perennial Investment Advisors, LLC with notifications on news.